Related Experiment Video
Updated: Aug 2, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
Published on: June 26, 2014
A reimbursable education service for patients with hepatitis C
1University of Texas-El Paso/University of Texas-Austin Cooperative Pharmacy Program, USA.
Objective:
To describe a pharmacy's subcutaneous injection education service for patients with hepatitis C. PRACTICE PROBLEM: Obstacles identified in the delivery of the service included the need to increase the pharmacists' level of knowledge regarding hepatitis C, establish methods for consistent education and documentation of patient education sessions, and improve coordination of scheduling appointments, pharmacy workflow, and obtaining documentation from physicians for reimbursement.
Practice Innovation:
In this pharmacist-coordinated hepatitis C education service, policies and procedures were developed and implemented to ensure uniform standards of patient care and to improve pharmacists' knowledge base, patient education, and documentation of services. A one-page, faxable treatment order form was designed to help streamline physician office documentation and workflow. A task flow sheet for each patient case was used to address additional scheduling and workflow issues. Third party payers were billed for every teaching session.
Results:
After evaluating the service and implementing several improvements, coordination of patient care became more streamlined. From March 1997 through February 2000, 94 patients received care, with appointments lasting between 45 and 90 minutes. Reimbursement was obtained from third party payers for 19% (18/94) of the teaching sessions. When claims were rejected, patients were billed for the education service.
Conclusion:
Pharmacists have an opportunity to provide a reimbursable education service to patients with hepatitis C.
Related Concept Videos
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
Chronic Pancreatitis II: Collaborative Care
Assessment:
Continuous Renal Replacement Therapy
Chronic Kidney Disease III: Interprofessional Care
Hepatitis
Viral Hepatitis I: Introduction

